HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lodewyk F A Wessels Selected Research

Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)

4/2014Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lodewyk F A Wessels Research Topics

Disease

70Neoplasms (Cancer)
05/2022 - 05/2005
34Breast Neoplasms (Breast Cancer)
05/2022 - 05/2005
7Colonic Neoplasms (Colon Cancer)
02/2021 - 11/2012
5Prostatic Neoplasms (Prostate Cancer)
01/2022 - 11/2015
5Colorectal Neoplasms (Colorectal Cancer)
02/2020 - 02/2014
5Neoplasm Metastasis (Metastasis)
01/2020 - 01/2006
4Squamous Cell Carcinoma of Head and Neck
03/2019 - 02/2005
3Noninfiltrating Intraductal Carcinoma (DCIS)
01/2022 - 07/2011
3Carcinoma (Carcinomatosis)
03/2019 - 07/2007
3Triple Negative Breast Neoplasms
01/2019 - 10/2015
2Inflammation (Inflammations)
01/2019 - 01/2019
2Hypersensitivity (Allergy)
04/2018 - 05/2014
1Tertiary Lymphoid Structures
01/2021
1Lobular Carcinoma
01/2020
1Head and Neck Neoplasms (Head and Neck Cancer)
03/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018
1Pathologic Complete Response
01/2018
1Endometrial Neoplasms (Endometrial Cancer)
01/2017
1Genetic Translocation (Chromosomal Translocation)
01/2016
1Autoimmune Diseases (Autoimmune Disease)
10/2015
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2015
1Melanoma (Melanoma, Malignant)
04/2014
1Microsatellite Instability
02/2014

Drug/Important Bio-Agent (IBA)

18DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2005
12Pharmaceutical PreparationsIBA
01/2022 - 11/2012
11Biomarkers (Surrogate Marker)IBA
05/2022 - 07/2014
8Estrogen ReceptorsIBA
01/2020 - 07/2007
7Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2021 - 11/2012
7TamoxifenFDA LinkGeneric
01/2020 - 01/2009
6Messenger RNA (mRNA)IBA
03/2022 - 01/2010
5RNA (Ribonucleic Acid)IBA
05/2022 - 02/2010
5Androgen Receptors (Androgen Receptor)IBA
01/2022 - 11/2015
5Phosphotransferases (Kinase)IBA
02/2020 - 11/2012
5ChromatinIBA
01/2018 - 04/2014
4Biological ProductsIBA
01/2022 - 02/2014
4Proteins (Proteins, Gene)FDA Link
03/2021 - 01/2013
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 05/2005
3Transcription Factors (Transcription Factor)IBA
02/2020 - 03/2013
3PlatinumIBA
03/2019 - 06/2013
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2015 - 05/2005
2Proteasome Endopeptidase Complex (Proteasome)IBA
12/2021 - 01/2020
2Hormones (Hormone)IBA
02/2020 - 01/2016
2(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA
01/2020 - 11/2016
2LigandsIBA
01/2019 - 10/2018
2Estrogens (Estrogen)FDA Link
03/2017 - 01/2017
2Small Interfering RNA (siRNA)IBA
03/2017 - 04/2014
2Histones (Histone)IBA
01/2017 - 07/2015
2Trastuzumab (Herceptin)FDA Link
11/2016 - 01/2016
2Formaldehyde (Formol)FDA Link
03/2016 - 02/2011
2Phenobarbital (Luminal)FDA Link
07/2014 - 01/2010
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
05/2014 - 06/2013
2ErbB Receptors (EGF Receptor)IBA
04/2014 - 11/2012
2MicroRNAs (MicroRNA)IBA
01/2014 - 07/2011
1AndrogensIBA
01/2022
1enzalutamideIBA
01/2022
1TransactIBA
12/2021
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2021
1SenotherapeuticsIBA
01/2021
1NivolumabIBA
12/2020
1IpilimumabIBA
12/2020
1tyrosine receptor (receptor, tyrosine)IBA
02/2020
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2020
1EndonucleasesIBA
01/2020
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
01/2020
1Therapeutic UsesIBA
01/2020
1Programmed Cell Death 1 ReceptorIBA
01/2019
1Glycoside Hydrolases (Endoglycosidases)IBA
11/2018
1Poly Adenosine Diphosphate RiboseIBA
11/2018
1AZD4547IBA
10/2018
1Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2018
1A 19IBA
04/2018
1Mitomycin (Mitomycin-C)FDA LinkGeneric
04/2018
1Mitogen-Activated Protein KinasesIBA
01/2018
1neratinibIBA
01/2018
1EverolimusFDA Link
08/2017
1Cadherins (E-Cadherin)IBA
08/2017
1Epidermal Growth Factor (EGF)IBA
03/2017
1Lysine (L-Lysine)FDA Link
01/2017
1MK 2206IBA
11/2016
1GSK-2816126IBA
10/2016
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
03/2016
1Cytidine DeaminaseIBA
01/2016
1Interleukin-17 (Interleukin 17)IBA
10/2015
1HeterochromatinIBA
07/2015
1AclarubicinIBA
07/2015
1AnthracyclinesIBA
07/2015
1Alkylating AgentsIBA
05/2014
1Carboplatin (JM8)FDA LinkGeneric
05/2014
1SaltsIBA
05/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
04/2014
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
04/2014
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
04/2014
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
04/2014

Therapy/Procedure

21Therapeutics
03/2022 - 01/2006
14Drug Therapy (Chemotherapy)
05/2022 - 05/2005
6Neoadjuvant Therapy
05/2022 - 05/2005
2Segmental Mastectomy (Lumpectomy)
12/2021 - 03/2021
2Aftercare (After-Treatment)
01/2021 - 05/2005
2Chemoradiotherapy
03/2019 - 01/2018
1Immunotherapy
01/2021